Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL21816680

C[C@@H]1CN(C2CCNCC2)C[C@H](C)N1C.O=C(O)C(F)(F)F

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 2/20 0.33
DPP7 Q9UHL4 2/20 0.33
DPP4 P27487 1/20 0.33
WDR5 P61964 1/20 0.32
ARG1 P05089 1/20 0.32
ARG2 P78540 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
TSHR P16473 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA4 P48169 1/20 0.32
GABRE P78334 1/20 0.32
PMP22 Q01453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13210507 0.83 CHRM2 (0.32)
SCHEMBL25840435 0.83 CHRM2 (0.32)
Trifluoroacetic Acid SCHEMBL21816764 0.82 KDM4E (0.44) ARG1ARG2GABRPGABRDGABRA1
Trifluoroacetic Acid SCHEMBL994467 0.81 GABRP (0.35) ARG1ARG2GABRPGABRDGABRA1
Trifluoroacetic Acid SCHEMBL21816595 0.78 ALDH1A1 (0.36) DPP4GABRPGABRDGABRA1TSHR
Trifluoroacetic Acid SCHEMBL3332435 0.78 GABRP (0.35) DPP8DPP7DPP4GABRPGABRD
Trifluoroacetic Acid SCHEMBL29823097 0.77 HPGD (0.40) ARG1ARG2GABRPGABRDGABRA1
Trifluoroacetic Acid SCHEMBL3335491 0.75 DPP4 (0.35) DPP8DPP7DPP4ARG1ARG2
Trifluoroacetic Acid SCHEMBL3338294 0.75 DPP4 (0.35) DPP8DPP7DPP4ARG1ARG2
Trifluoroacetic Acid SCHEMBL3335481 0.75 DPP4 (0.35) DPP8DPP7DPP4ARG1ARG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3640248-B1 AMINOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF BEIJING ADAMADLE BIOTECHNOLOGY LLC (CN) 2023-08-23 EP disclosed
US-20200087296-A1 AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Beijing Adamadle Biotechnology Limited Liability Company (CN) 2020-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200087296-A1 AMINOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF WEE1, WEE2, EGFR DPP8 525/4885DPP7 854/4885DPP4 1161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.